Trait: intracerebral hemorrhage

Experimental Factor Ontology (EFO) Information
Identifier EFO_0005669
Description Bleeding into one or both cerebral hemispheres including the basal ganglia and the cerebral cortex. It is often associated with hypertension and craniocerebral trauma. [MESH: D002543]
Trait categories
Cardiovascular disease
Neurological disorder
Synonyms 2 synonyms
  • intracerebral hemorrhage
  • stroke, hemorrhagic
Mapped terms 9 mapped terms
  • ICD10:I61
  • ICD9:431
  • MEDGEN:423648
  • MESH:D002543
  • MONDO:0013792
  • MedDRA:10022754
  • OMIM:614519
  • SCTID:274100004
  • UMLS:C2937358

Associated Polygenic Score(s)

Filter PGS by Participant Ancestry
Individuals included in:
G - Source of Variant Associations (GWAS)
D - Score Development/Training
E - PGS Evaluation
List of ancestries includes:
Display options:
Ancestry legend
Multi-ancestry (including European)
Multi-ancestry (excluding European)
African
East Asian
South Asian
Additional Asian Ancestries
European
Greater Middle Eastern
Hispanic or Latin American
Additional Diverse Ancestries
Not Reported
Polygenic Score ID & Name PGS Publication ID (PGP) Reported Trait Mapped Trait(s) (Ontology) Number of Variants Ancestry distribution
GWAS
Dev
Eval
Scoring File (FTP Link)
PGS003457
(GRS_ICH)
PGP000450 |
Mayerhofer E et al. Stroke (2023)
Intracerebral hemorrhage intracerebral hemorrhage 682,890
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003457/ScoringFiles/PGS003457.txt.gz
PGS004943
(ICH_MetaPRS)
PGP000668 |
China Kadoorie Biobank Collaborative Group. et al. Nat Hum Behav (2024)
Intracerebral hemorrhage intracerebral hemorrhage 2,124,631
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004943/ScoringFiles/PGS004943.txt.gz

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
Evaluated Score PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM017258 PGS003457
(GRS_ICH)
PSS010179|
Multi-ancestry (including European)|
5,530 individuals
PGP000450 |
Mayerhofer E et al. Stroke (2023)
Reported Trait: Incident intracerebral hemorrhage in anticoagulation therapy HR: 1.24 [1.01, 1.53] : 0.02 age at baseline (controls) or ICH event (cases), sex, PC1 to 10, and genotyping array
PPM017259 PGS003457
(GRS_ICH)
PSS010179|
Multi-ancestry (including European)|
5,530 individuals
PGP000450 |
Mayerhofer E et al. Stroke (2023)
Reported Trait: Incident intracerebral hemorrhage in anticoagulation therapy HR: 1.33 [1.11, 1.59] C-index: 0.57 [0.5, 0.64] age at baseline (controls) or ICH event (cases), sex, PC1 to 10, and genotyping array, clinical risk score
PPM021741 PGS004943
(ICH_MetaPRS)
PSS011773|
East Asian Ancestry|
72,149 individuals
PGP000668 |
China Kadoorie Biobank Collaborative Group. et al. Nat Hum Behav (2024)
Reported Trait: Incident intracerebral hemorrhage HR: 1.31 [1.24, 1.39] C-index: 0.748 [0.734, 0.761] age, sex

Evaluated Samples

PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS011773 ICD10: I61 Median = 12.2 years 72,149 individuals,
40.2 % Male samples
Mean = 51.7 years
Sd = 10.5 years
East Asian
(Chinese)
CKB
PSS010179 The test cohort consisted of individuals without a history of ICH at baseline and anticoagulant use defined by self-report in the verbal interview at inclusion. Furthermore, individuals were included if they had a diagnosis of the International Classification of Diseases, Tenth Revision code Z92.1 (personal history of long-term (current) use of anticoagulants) or D68.3 (hemorrhagic disorder due to circulating anticoagulants) at baseline or a prescription of an anticoagulant medication between baseline and 6 months thereafter in the primary care data Mean = 11.9 years
[
  • 86 cases
  • , 4,972 controls
]
,
69.0 % Male samples
Mean = 62.0 years European UKB
PSS010179 The test cohort consisted of individuals without a history of ICH at baseline and anticoagulant use defined by self-report in the verbal interview at inclusion. Furthermore, individuals were included if they had a diagnosis of the International Classification of Diseases, Tenth Revision code Z92.1 (personal history of long-term (current) use of anticoagulants) or D68.3 (hemorrhagic disorder due to circulating anticoagulants) at baseline or a prescription of an anticoagulant medication between baseline and 6 months thereafter in the primary care data Mean = 11.9 years
[
  • 8 cases
  • , 464 controls
]
,
69.0 % Male samples
Mean = 62.0 years Not reported UKB